SAT0026 ACHIEVEMENT OF REMISSION – A SOCIO-ECONOMIC POINT OF VIEW
H. Radner 1,*D. Aletaha 1J. Smolen 1
1Department of Rheumatology, MEDICAL UNIVERSITY VIENNA, Vienna, Austria
Background: Rheumatoid Arthritis (RA) as a highly prevalent chronic disease leads to a considerable socio-economic burden which is mainly mediated by functional impairment. Recent management recommendations focus on achieving clinical remission (REM), but it is not yet clear whether targeting remission is effective from a socioeconomic view when compared with less stringent treatment goals such as low disease activity (LDA).
Objectives: To evaluate the socioeconomic burden in RA patient with remission compared to those in LDA.
Methods: In 356 consecutive RA patients we obtained data of physical function (Health Assessment Questionnaire HAQ), Quality of life (Short Form 36 (SF36); Euro Qol 5D (EQ-5D)), work productivity (Work Productivity and Activity Impairment Questionnaire (WPAI)), disease activity (Clinical disease activity Index (CDAI)) and cross-sectionally compared data obtained in patients with remission (REM CDAI<2.8; n=89) with those of patients in low disease activity (LDA 2.8<CDAI<10; n=152) using Student´s t-Test.
For preliminary longitudinal analyses we identified 100 patients (REM n=34; LDA n=66) who were followed over one year period, and calculated average quality of life (using EQ-5D), productivity, and functional disability over this one year.
Results: Cross-sectional we found a statistically significant difference (p<0.01) in patients achieving REM compared to those in LDA regarding physical function (HAQ: 0.38 vs. 0.75), productivity (WPAI: percent impairment while working 11.3% vs. 27.2%; percent of overall activity impairment 18.1% vs. 33.8%) and quality of life (EQ-5D: 0.89 vs. 0.78; SF-36 PCS: 46.2 vs. 37.8; MCS: 49.4 vs. 48.9; domains see figure 1). All comparisons except for the domain role emotional and MCS were statistically significant different in favor of REM.
Preliminary longitudinal comparison of patients in REM and LDA showed significant differences in quality of life (0.87 vs. 0.80, p=0.009), percent of overall activity impairment per year (16.0% vs. 30.0%, p=0.002), and physical disability over one year (HAQy: 0.22 vs. 0.74, p<0.001), but no difference regarding percent of impairment while working per year (14.2% vs. 16.6%, p=0.78).
Image / Graph:
Conclusion: Regarding important outcomes like physical function, productivity or quality of life, remission is even superior to another good clinical state, namely, low disease activity. Therefore aiming for remission therefore seems worthwhile even in patients who have attained LDA.
Disclosure of Interest: H. Radner Grant / Research Support from: UCBD. Aletaha Grant / Research Support from: UCBJ. Smolen Grant / Research Support from: UCB